Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8

8 clinical trials · Condition

Record	Firm	Date
Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery (NCT04391049)	NRG Oncology	2021-12-02
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer (NCT04615013)	M.D. Anderson Cancer Center	2020-11-23
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma (NCT04111172)	Thomas Jefferson University	2020-11-10
Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study (NCT04449679)	Thomas Jefferson University	2020-04-15
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)	City of Hope Medical Center	2019-12-24
Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT04097028)	Roswell Park Cancer Institute	2019-12-20
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes (NCT04183218)	Mayo Clinic	2019-09-23
Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma (NCT03784326)	M.D. Anderson Cancer Center	2019-02-19

Every clearance here is in the API, with alerts when new ones post.